Status:

UNKNOWN

Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip

Lead Sponsor:

Al-Azhar University

Conditions:

Orthopedic Disorder

Eligibility:

All Genders

9-60 years

Brief Summary

The treatment of developmental dysplasia of the hip (DDH) remains challenging, yet recent advances have refined our understanding of how best to survey for the condition during infancy, minimize compl...

Detailed Description

it is an operative technique to secure the femoral head after reduction in cases of developmental dysplasia of the hip Operative technique: The surgery will be accomplished under a general anesthesi...

Eligibility Criteria

Inclusion

  • Patient with Developmental dysplasia of the hip (DDH) with :
  • Age: from 9 months -5 years old.
  • Virgin DDH.
  • Failed closed reduction in the management of DDH.
  • Failed open reduction through medial approach in the management of DDH

Exclusion

  • • Paralytic hip dislocation .
  • Post septic hip dislocation.
  • Traumatic hip dislocation .
  • Age : below 9 months or above 5 years.
  • Refusal to participate in this study.

Key Trial Info

Start Date :

July 21 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05432505

Start Date

July 21 2022

End Date

February 1 2023

Last Update

June 27 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip | DecenTrialz